2.8(top 20%)
impact factor
2.1K(top 10%)
papers
33.1K(top 10%)
citations
65(top 10%)
h-index
2.9(top 20%)
impact factor
2.3K
all documents
34.7K
doc citations
92(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy and Radiopharmaceuticals1997350
2Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical ResearchCancer Biotherapy and Radiopharmaceuticals2009302
3Growing Applications of “Click Chemistry” for Bioconjugation in Contemporary Biomedical ResearchCancer Biotherapy and Radiopharmaceuticals2009254
4Affinity and Avidity in Antibody-Based Tumor TargetingCancer Biotherapy and Radiopharmaceuticals2009185
5A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (anti αvβ3) Antibody in Patients with Metastatic CancerCancer Biotherapy and Radiopharmaceuticals2001172
6Structure and Function of Bone Marrow Hemopoiesis: Mechanisms of Response to Ionizing Radiation ExposureCancer Biotherapy and Radiopharmaceuticals2002169
7Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOCCancer Biotherapy and Radiopharmaceuticals2007155
8Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor TargetingCancer Biotherapy and Radiopharmaceuticals2002153
9Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast CancerCancer Biotherapy and Radiopharmaceuticals1999145
10Phase I-II Study of Radiopeptide177Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine TumorsCancer Biotherapy and Radiopharmaceuticals2012144
11Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and RadiationCancer Biotherapy and Radiopharmaceuticals1999136
12Feasibility of Dosimetry-Based High-Dose 131I-Meta-Iodobenzylguanidine with Topotecan as a Radiosensitizer in Children with Metastatic NeuroblastomaCancer Biotherapy and Radiopharmaceuticals2005132
13Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)Cancer Biotherapy and Radiopharmaceuticals2010129
14Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other TumorsCancer Biotherapy and Radiopharmaceuticals2010125
15Cancer ImmunotherapyCancer Biotherapy and Radiopharmaceuticals2011120
16Pre-Targeted Locoregional Radioimmunotherapy with 90Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic ResultsCancer Biotherapy and Radiopharmaceuticals2001115
17Infliximab in the Treatment of Anti-CTLA4 Antibody (Ipilimumab) Induced Immune-Related ColitisCancer Biotherapy and Radiopharmaceuticals2009113
18Long-Lived Positron Emitters Zirconium-89 and Iodine-124 for Scouting of Therapeutic Radioimmunoconjugates with PETCancer Biotherapy and Radiopharmaceuticals2003111
19Receptor-Binding, Biodistribution, and Metabolism Studies of64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive TumorsCancer Biotherapy and Radiopharmaceuticals2008111
20Positron Emission Tomography (PET) for Staging of Solitary PlasmacytomaCancer Biotherapy and Radiopharmaceuticals2003110
21Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study ResultsCancer Biotherapy and Radiopharmaceuticals2000109
22Slow Internalization of Anti-HER2 Synthetic Affibody Monomer111In-DOTA-ZHER2:342-pep2: Implications for Development of Labeled TracersCancer Biotherapy and Radiopharmaceuticals2008108
23Pharmacokinetics and Imaging of212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer PatientsCancer Biotherapy and Radiopharmaceuticals2014106
24Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine KinasesCancer Biotherapy and Radiopharmaceuticals2001105
25The Radioprotective Effect of Zataria multiflora Against Genotoxicity Induced by γ Irradiation in Human Blood LymphocytesCancer Biotherapy and Radiopharmaceuticals2011104
26Abscopal Regression of Antigen Disparate Tumors by Antigen Cascade After Systemic Tumor Vaccination in Combination with Local Tumor RadiationCancer Biotherapy and Radiopharmaceuticals2012101
27Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced AutophagyCancer Biotherapy and Radiopharmaceuticals2010100
28Peptide Receptor Radionuclide Therapy: An OverviewCancer Biotherapy and Radiopharmaceuticals201597
29α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a 212Pb-Labeled Radioimmunoconjugate Targeting HER2Cancer Biotherapy and Radiopharmaceuticals200595
30Rhenium-188 - A Generator-Derived Radioisotope for Cancer TherapyCancer Biotherapy and Radiopharmaceuticals199894
31Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid CarcinomasCancer Biotherapy and Radiopharmaceuticals200494
32Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle TherapyCancer Biotherapy and Radiopharmaceuticals201394
33The Radiobiology of Conventional Radiotherapy and Its Application to Radionuclide TherapyCancer Biotherapy and Radiopharmaceuticals200593
34Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody TherapyCancer Biotherapy and Radiopharmaceuticals201093
35Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future PerspectivesCancer Biotherapy and Radiopharmaceuticals201793
36Induction of CA125-Specific B and T Cell Responses in Patients Injected with MAb-B43.13—Evidence for Antibody-Mediated Antigen-Processing and Presentation of CA125 in VivoCancer Biotherapy and Radiopharmaceuticals200192
37Inhibition of Cell Growth in Culture by QuinonesCancer Biotherapy and Radiopharmaceuticals199890
38Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation ApproachesCancer Biotherapy and Radiopharmaceuticals201889
39FDG-PET in Adrenocortical CarcinomaCancer Biotherapy and Radiopharmaceuticals200188
40Eugenol Enhances the Chemotherapeutic Potential of Gemcitabine and Induces Anticarcinogenic and Anti-inflammatory Activity in Human Cervical Cancer CellsCancer Biotherapy and Radiopharmaceuticals201188
41In Vitro Characterization of a Bivalent Anti-HER-2 Affibody with Potential for Radionuclide-Based DiagnosticsCancer Biotherapy and Radiopharmaceuticals200587
42Radiolabeling of Extracellular Vesicles with 99mTc for Quantitative In Vivo Imaging StudiesCancer Biotherapy and Radiopharmaceuticals201686
43Selective Internal Radiation Therapy with SIR-Spheres® in Patients with Nonresectable Liver TumorsCancer Biotherapy and Radiopharmaceuticals200584
44Anticancer Activity and Molecular Mechanism of Resveratrol–Bovine Serum Albumin Nanoparticles on Subcutaneously Implanted Human Primary Ovarian Carcinoma Cells in Nude MiceCancer Biotherapy and Radiopharmaceuticals201083
45AttenuatedSalmonella typhimuriumContaining Interleukin-2 Decreases MC-38 Hepatic Metastases: A Novel Anti-tumor AgentCancer Biotherapy and Radiopharmaceuticals199682
46Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using131I-LYM-1 AntibodyCancer Biotherapy and Radiopharmaceuticals199882
47Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma CellsCancer Biotherapy and Radiopharmaceuticals201381
48NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I StudyCancer Biotherapy and Radiopharmaceuticals201580
49Radionuclide Therapy with Iodine-125 and Other Auger–Electron-Emitting Radionuclides: Experimental Models and Clinical ApplicationsCancer Biotherapy and Radiopharmaceuticals200376
50Design, Synthesis, and Evaluation of Radiolabeled Integrin αvβ3 Receptor Antagonists for Tumor Imaging and RadiotherapyCancer Biotherapy and Radiopharmaceuticals200376